I have you loud and clear.

Hello.

Hello.

Welcome.

Science.

And that is the say, physics, medicine, nature, space, time, brain, life, the universe.

This week, Alzheimer's disease, a third of the population

may be destined to develop this form of dementia, which robs people of their memories and their independence

So what causes it and what can we do about it?

Plus in the news Nice approves a new drug for an aggressive form of lung cancer. We've got the low down on

the Nobel Prizes and how a computer code has been released online that could be

using your devices to launch cyber attacks. I'm Katani. And I'm Chris Smith and you're listening to

The Naked Scientists. The Naked Scientists podcast is powered by UKfast.ast.K. First, a new drug to combat one of the more aggressive forms of lung cancer has been approved by Nice, that's the

UK's National Institute for Health and Care Excellence. It's been developed at record

breaking speed by the company AstraZeneca and in clinical trials almost twice as many patients

responded to the new agent called Ozzy Mertinib compared with existing chemotherapy.

Cancer Specialist Alistoque, one of the investigators who's been testing the new drug,

told Chris how it works and who might benefit.

Osmurtinib is a new drug that's become available for patients with a rare type of lung cancer. It's lung cancer

that's got a mutation in a protein called epider. This protein is like a

switch that turns on and then drives the cell's growth, makes it grow, make it spread,

divide core symptoms to the patient.

...